Chiang Mai Ram Medical Business PCL (BKK:CMR)
Thailand · Delayed Price · Currency is THB 1.410
+0.010 (0.71%)
Feb 10, 2026, 4:36 PM ICT
BKK:CMR Income Statement
Financials in millions THB. Fiscal year is January - December.
Millions THB. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Operating Revenue | 5,088 | 5,288 | 5,066 | 5,205 | 4,193 | 3,668 |
Other Revenue | 118.42 | 65.41 | 78.72 | 64.48 | 51.08 | 48.97 |
| 5,206 | 5,353 | 5,144 | 5,269 | 4,244 | 3,717 | |
Revenue Growth (YoY) | -4.03% | 4.06% | -2.37% | 24.17% | 14.17% | -6.26% |
Cost of Revenue | 4,148 | 4,103 | 3,914 | 3,792 | 3,255 | 2,861 |
Gross Profit | 1,058 | 1,250 | 1,230 | 1,477 | 988.66 | 855.73 |
Selling, General & Admin | 792.69 | 837.24 | 712.34 | 657.84 | 528.56 | 537.41 |
Operating Expenses | 792.69 | 837.24 | 712.34 | 657.84 | 528.56 | 537.41 |
Operating Income | 265.46 | 412.74 | 518.13 | 819.27 | 460.1 | 318.31 |
Interest Expense | -143.12 | -152.76 | -148.17 | -119.12 | -86.04 | -75.76 |
Interest & Investment Income | 21.54 | 71.55 | 99.9 | 82.04 | 68.28 | 69.65 |
Earnings From Equity Investments | -3.31 | 3.56 | 15.13 | 18.04 | 11.95 | 1.13 |
EBT Excluding Unusual Items | 140.57 | 335.1 | 485 | 800.23 | 454.29 | 313.33 |
Gain (Loss) on Sale of Investments | - | - | - | 35.25 | - | - |
Gain (Loss) on Sale of Assets | - | - | - | - | -0.22 | -2.23 |
Pretax Income | 140.57 | 335.1 | 485 | 835.47 | 454.07 | 311.1 |
Income Tax Expense | 237.48 | 93.38 | 102.14 | 151.31 | 77.89 | 67.52 |
Earnings From Continuing Operations | -96.91 | 241.72 | 382.86 | 684.16 | 376.18 | 243.58 |
Minority Interest in Earnings | 30.33 | -111.21 | -165.1 | -180.31 | -84.09 | -45.47 |
Net Income | -66.58 | 130.51 | 217.75 | 503.86 | 292.09 | 198.11 |
Net Income to Common | -66.58 | 130.51 | 217.75 | 503.86 | 292.09 | 198.11 |
Net Income Growth | - | -40.07% | -56.78% | 72.50% | 47.44% | 25.33% |
Shares Outstanding (Basic) | 4,071 | 4,071 | 4,046 | 4,023 | 4,023 | 4,023 |
Shares Outstanding (Diluted) | 4,071 | 4,071 | 4,046 | 4,023 | 4,023 | 4,023 |
Shares Change (YoY) | -0.00% | 0.62% | 0.57% | - | - | - |
EPS (Basic) | -0.02 | 0.03 | 0.05 | 0.13 | 0.07 | 0.05 |
EPS (Diluted) | -0.02 | 0.03 | 0.05 | 0.13 | 0.07 | 0.05 |
EPS Growth | - | -40.44% | -57.03% | 72.50% | 47.44% | 25.33% |
Free Cash Flow | 378.76 | 626.08 | 642.64 | 749.9 | -235.51 | -779.03 |
Free Cash Flow Per Share | 0.09 | 0.15 | 0.16 | 0.19 | -0.06 | -0.19 |
Dividend Per Share | 0.268 | 0.050 | 0.055 | 0.066 | 0.065 | 0.052 |
Dividend Growth | 387.82% | -9.09% | -16.67% | 1.54% | 25.00% | -11.11% |
Gross Margin | 20.32% | 23.35% | 23.92% | 28.03% | 23.30% | 23.02% |
Operating Margin | 5.10% | 7.71% | 10.07% | 15.55% | 10.84% | 8.56% |
Profit Margin | -1.28% | 2.44% | 4.23% | 9.56% | 6.88% | 5.33% |
Free Cash Flow Margin | 7.27% | 11.70% | 12.49% | 14.23% | -5.55% | -20.96% |
EBITDA | 715.22 | 883.42 | 1,008 | 1,283 | 802.2 | 591.87 |
EBITDA Margin | 13.74% | 16.50% | 19.59% | 24.34% | 18.90% | 15.92% |
D&A For EBITDA | 449.77 | 470.68 | 489.71 | 463.48 | 342.11 | 273.56 |
EBIT | 265.46 | 412.74 | 518.13 | 819.27 | 460.1 | 318.31 |
EBIT Margin | 5.10% | 7.71% | 10.07% | 15.55% | 10.84% | 8.56% |
Effective Tax Rate | 168.94% | 27.87% | 21.06% | 18.11% | 17.15% | 21.70% |
Revenue as Reported | 5,228 | 5,425 | 5,244 | 5,387 | 4,312 | 3,784 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.